Global Hip Osteoarthritis Pain Medicine Market Growth 2024-2031

Report ID: 1358325 | Published Date: Sep 2024 | No. of Page: 110 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Hip Osteoarthritis Pain Medicine Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Hip Osteoarthritis Pain Medicine by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Hip Osteoarthritis Pain Medicine by Country/Region, 2017, 2022 & 2028
    2.2 Hip Osteoarthritis Pain Medicine Segment by Type
        2.2.1 Oral
        2.2.2 Injection
        2.2.3 External
    2.3 Hip Osteoarthritis Pain Medicine Sales by Type
        2.3.1 Global Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2017-2022)
        2.3.2 Global Hip Osteoarthritis Pain Medicine Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Hip Osteoarthritis Pain Medicine Sale Price by Type (2017-2022)
    2.4 Hip Osteoarthritis Pain Medicine Segment by Application
        2.4.1 Medical Care
        2.4.2 Personal Care
    2.5 Hip Osteoarthritis Pain Medicine Sales by Application
        2.5.1 Global Hip Osteoarthritis Pain Medicine Sale Market Share by Application (2017-2022)
        2.5.2 Global Hip Osteoarthritis Pain Medicine Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Hip Osteoarthritis Pain Medicine Sale Price by Application (2017-2022)
3 Global Hip Osteoarthritis Pain Medicine by Company
    3.1 Global Hip Osteoarthritis Pain Medicine Breakdown Data by Company
        3.1.1 Global Hip Osteoarthritis Pain Medicine Annual Sales by Company (2020-2022)
        3.1.2 Global Hip Osteoarthritis Pain Medicine Sales Market Share by Company (2020-2022)
    3.2 Global Hip Osteoarthritis Pain Medicine Annual Revenue by Company (2020-2022)
        3.2.1 Global Hip Osteoarthritis Pain Medicine Revenue by Company (2020-2022)
        3.2.2 Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Company (2020-2022)
    3.3 Global Hip Osteoarthritis Pain Medicine Sale Price by Company
    3.4 Key Manufacturers Hip Osteoarthritis Pain Medicine Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Hip Osteoarthritis Pain Medicine Product Location Distribution
        3.4.2 Players Hip Osteoarthritis Pain Medicine Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hip Osteoarthritis Pain Medicine by Geographic Region
    4.1 World Historic Hip Osteoarthritis Pain Medicine Market Size by Geographic Region (2017-2022)
        4.1.1 Global Hip Osteoarthritis Pain Medicine Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Hip Osteoarthritis Pain Medicine Annual Revenue by Geographic Region
    4.2 World Historic Hip Osteoarthritis Pain Medicine Market Size by Country/Region (2017-2022)
        4.2.1 Global Hip Osteoarthritis Pain Medicine Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Hip Osteoarthritis Pain Medicine Annual Revenue by Country/Region
    4.3 Americas Hip Osteoarthritis Pain Medicine Sales Growth
    4.4 APAC Hip Osteoarthritis Pain Medicine Sales Growth
    4.5 Europe Hip Osteoarthritis Pain Medicine Sales Growth
    4.6 Middle East & Africa Hip Osteoarthritis Pain Medicine Sales Growth
5 Americas
    5.1 Americas Hip Osteoarthritis Pain Medicine Sales by Country
        5.1.1 Americas Hip Osteoarthritis Pain Medicine Sales by Country (2017-2022)
        5.1.2 Americas Hip Osteoarthritis Pain Medicine Revenue by Country (2017-2022)
    5.2 Americas Hip Osteoarthritis Pain Medicine Sales by Type
    5.3 Americas Hip Osteoarthritis Pain Medicine Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Hip Osteoarthritis Pain Medicine Sales by Region
        6.1.1 APAC Hip Osteoarthritis Pain Medicine Sales by Region (2017-2022)
        6.1.2 APAC Hip Osteoarthritis Pain Medicine Revenue by Region (2017-2022)
    6.2 APAC Hip Osteoarthritis Pain Medicine Sales by Type
    6.3 APAC Hip Osteoarthritis Pain Medicine Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Hip Osteoarthritis Pain Medicine by Country
        7.1.1 Europe Hip Osteoarthritis Pain Medicine Sales by Country (2017-2022)
        7.1.2 Europe Hip Osteoarthritis Pain Medicine Revenue by Country (2017-2022)
    7.2 Europe Hip Osteoarthritis Pain Medicine Sales by Type
    7.3 Europe Hip Osteoarthritis Pain Medicine Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Hip Osteoarthritis Pain Medicine by Country
        8.1.1 Middle East & Africa Hip Osteoarthritis Pain Medicine Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Hip Osteoarthritis Pain Medicine Revenue by Country (2017-2022)
    8.2 Middle East & Africa Hip Osteoarthritis Pain Medicine Sales by Type
    8.3 Middle East & Africa Hip Osteoarthritis Pain Medicine Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Hip Osteoarthritis Pain Medicine
    10.3 Manufacturing Process Analysis of Hip Osteoarthritis Pain Medicine
    10.4 Industry Chain Structure of Hip Osteoarthritis Pain Medicine
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Hip Osteoarthritis Pain Medicine Distributors
    11.3 Hip Osteoarthritis Pain Medicine Customer
12 World Forecast Review for Hip Osteoarthritis Pain Medicine by Geographic Region
    12.1 Global Hip Osteoarthritis Pain Medicine Market Size Forecast by Region
        12.1.1 Global Hip Osteoarthritis Pain Medicine Forecast by Region (2023-2028)
        12.1.2 Global Hip Osteoarthritis Pain Medicine Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Hip Osteoarthritis Pain Medicine Forecast by Type
    12.7 Global Hip Osteoarthritis Pain Medicine Forecast by Application
13 Key Players Analysis
    13.1 Pfizer
        13.1.1 Pfizer Company Information
        13.1.2 Pfizer Hip Osteoarthritis Pain Medicine Product Offered
        13.1.3 Pfizer Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Pfizer Main Business Overview
        13.1.5 Pfizer Latest Developments
    13.2 Johnson and Johnson
        13.2.1 Johnson and Johnson Company Information
        13.2.2 Johnson and Johnson Hip Osteoarthritis Pain Medicine Product Offered
        13.2.3 Johnson and Johnson Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Johnson and Johnson Main Business Overview
        13.2.5 Johnson and Johnson Latest Developments
    13.3 GlaxoSmithKline
        13.3.1 GlaxoSmithKline Company Information
        13.3.2 GlaxoSmithKline Hip Osteoarthritis Pain Medicine Product Offered
        13.3.3 GlaxoSmithKline Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 GlaxoSmithKline Main Business Overview
        13.3.5 GlaxoSmithKline Latest Developments
    13.4 Bayer
        13.4.1 Bayer Company Information
        13.4.2 Bayer Hip Osteoarthritis Pain Medicine Product Offered
        13.4.3 Bayer Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Bayer Main Business Overview
        13.4.5 Bayer Latest Developments
    13.5 Eli Lilly
        13.5.1 Eli Lilly Company Information
        13.5.2 Eli Lilly Hip Osteoarthritis Pain Medicine Product Offered
        13.5.3 Eli Lilly Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Eli Lilly Main Business Overview
        13.5.5 Eli Lilly Latest Developments
    13.6 Novartis
        13.6.1 Novartis Company Information
        13.6.2 Novartis Hip Osteoarthritis Pain Medicine Product Offered
        13.6.3 Novartis Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Novartis Main Business Overview
        13.6.5 Novartis Latest Developments
    13.7 Sanofi
        13.7.1 Sanofi Company Information
        13.7.2 Sanofi Hip Osteoarthritis Pain Medicine Product Offered
        13.7.3 Sanofi Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Sanofi Main Business Overview
        13.7.5 Sanofi Latest Developments
    13.8 Horizon Pharma
        13.8.1 Horizon Pharma Company Information
        13.8.2 Horizon Pharma Hip Osteoarthritis Pain Medicine Product Offered
        13.8.3 Horizon Pharma Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Horizon Pharma Main Business Overview
        13.8.5 Horizon Pharma Latest Developments
    13.9 Abbott
        13.9.1 Abbott Company Information
        13.9.2 Abbott Hip Osteoarthritis Pain Medicine Product Offered
        13.9.3 Abbott Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Abbott Main Business Overview
        13.9.5 Abbott Latest Developments
    13.10 Mylan
        13.10.1 Mylan Company Information
        13.10.2 Mylan Hip Osteoarthritis Pain Medicine Product Offered
        13.10.3 Mylan Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Mylan Main Business Overview
        13.10.5 Mylan Latest Developments
    13.11 Daiichi Sankyo
        13.11.1 Daiichi Sankyo Company Information
        13.11.2 Daiichi Sankyo Hip Osteoarthritis Pain Medicine Product Offered
        13.11.3 Daiichi Sankyo Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Daiichi Sankyo Main Business Overview
        13.11.5 Daiichi Sankyo Latest Developments
    13.12 TEVA
        13.12.1 TEVA Company Information
        13.12.2 TEVA Hip Osteoarthritis Pain Medicine Product Offered
        13.12.3 TEVA Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 TEVA Main Business Overview
        13.12.5 TEVA Latest Developments
    13.13 Almatica Pharma
        13.13.1 Almatica Pharma Company Information
        13.13.2 Almatica Pharma Hip Osteoarthritis Pain Medicine Product Offered
        13.13.3 Almatica Pharma Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Almatica Pharma Main Business Overview
        13.13.5 Almatica Pharma Latest Developments
    13.14 Astellas Pharma
        13.14.1 Astellas Pharma Company Information
        13.14.2 Astellas Pharma Hip Osteoarthritis Pain Medicine Product Offered
        13.14.3 Astellas Pharma Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 Astellas Pharma Main Business Overview
        13.14.5 Astellas Pharma Latest Developments
    13.15 Tide Pharmaceutical
        13.15.1 Tide Pharmaceutical Company Information
        13.15.2 Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Product Offered
        13.15.3 Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.15.4 Tide Pharmaceutical Main Business Overview
        13.15.5 Tide Pharmaceutical Latest Developments
    13.16 Iroko Pharmaceuticals
        13.16.1 Iroko Pharmaceuticals Company Information
        13.16.2 Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Product Offered
        13.16.3 Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.16.4 Iroko Pharmaceuticals Main Business Overview
        13.16.5 Iroko Pharmaceuticals Latest Developments
    13.17 Hengrui Pharmaceutical
        13.17.1 Hengrui Pharmaceutical Company Information
        13.17.2 Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Product Offered
        13.17.3 Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.17.4 Hengrui Pharmaceutical Main Business Overview
        13.17.5 Hengrui Pharmaceutical Latest Developments
    13.18 Abiogen Pharma
        13.18.1 Abiogen Pharma Company Information
        13.18.2 Abiogen Pharma Hip Osteoarthritis Pain Medicine Product Offered
        13.18.3 Abiogen Pharma Hip Osteoarthritis Pain Medicine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.18.4 Abiogen Pharma Main Business Overview
        13.18.5 Abiogen Pharma Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Hip Osteoarthritis Pain Medicine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Hip Osteoarthritis Pain Medicine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Oral
    Table 4. Major Players of Injection
    Table 5. Major Players of External
    Table 6. Global Hip Osteoarthritis Pain Medicine Sales by Type (2017-2022) & (K Units)
    Table 7. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2017-2022)
    Table 8. Global Hip Osteoarthritis Pain Medicine Revenue by Type (2017-2022) & ($ million)
    Table 9. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Type (2017-2022)
    Table 10. Global Hip Osteoarthritis Pain Medicine Sale Price by Type (2017-2022) & (USD/Unit)
    Table 11. Global Hip Osteoarthritis Pain Medicine Sales by Application (2017-2022) & (K Units)
    Table 12. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2017-2022)
    Table 13. Global Hip Osteoarthritis Pain Medicine Revenue by Application (2017-2022)
    Table 14. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Application (2017-2022)
    Table 15. Global Hip Osteoarthritis Pain Medicine Sale Price by Application (2017-2022) & (USD/Unit)
    Table 16. Global Hip Osteoarthritis Pain Medicine Sales by Company (2020-2022) & (K Units)
    Table 17. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Company (2020-2022)
    Table 18. Global Hip Osteoarthritis Pain Medicine Revenue by Company (2020-2022) ($ Millions)
    Table 19. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Company (2020-2022)
    Table 20. Global Hip Osteoarthritis Pain Medicine Sale Price by Company (2020-2022) & (USD/Unit)
    Table 21. Key Manufacturers Hip Osteoarthritis Pain Medicine Producing Area Distribution and Sales Area
    Table 22. Players Hip Osteoarthritis Pain Medicine Products Offered
    Table 23. Hip Osteoarthritis Pain Medicine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 24. New Products and Potential Entrants
    Table 25. Mergers & Acquisitions, Expansion
    Table 26. Global Hip Osteoarthritis Pain Medicine Sales by Geographic Region (2017-2022) & (K Units)
    Table 27. Global Hip Osteoarthritis Pain Medicine Sales Market Share Geographic Region (2017-2022)
    Table 28. Global Hip Osteoarthritis Pain Medicine Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 29. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Geographic Region (2017-2022)
    Table 30. Global Hip Osteoarthritis Pain Medicine Sales by Country/Region (2017-2022) & (K Units)
    Table 31. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Country/Region (2017-2022)
    Table 32. Global Hip Osteoarthritis Pain Medicine Revenue by Country/Region (2017-2022) & ($ millions)
    Table 33. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Country/Region (2017-2022)
    Table 34. Americas Hip Osteoarthritis Pain Medicine Sales by Country (2017-2022) & (K Units)
    Table 35. Americas Hip Osteoarthritis Pain Medicine Sales Market Share by Country (2017-2022)
    Table 36. Americas Hip Osteoarthritis Pain Medicine Revenue by Country (2017-2022) & ($ Millions)
    Table 37. Americas Hip Osteoarthritis Pain Medicine Revenue Market Share by Country (2017-2022)
    Table 38. Americas Hip Osteoarthritis Pain Medicine Sales by Type (2017-2022) & (K Units)
    Table 39. Americas Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2017-2022)
    Table 40. Americas Hip Osteoarthritis Pain Medicine Sales by Application (2017-2022) & (K Units)
    Table 41. Americas Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2017-2022)
    Table 42. APAC Hip Osteoarthritis Pain Medicine Sales by Region (2017-2022) & (K Units)
    Table 43. APAC Hip Osteoarthritis Pain Medicine Sales Market Share by Region (2017-2022)
    Table 44. APAC Hip Osteoarthritis Pain Medicine Revenue by Region (2017-2022) & ($ Millions)
    Table 45. APAC Hip Osteoarthritis Pain Medicine Revenue Market Share by Region (2017-2022)
    Table 46. APAC Hip Osteoarthritis Pain Medicine Sales by Type (2017-2022) & (K Units)
    Table 47. APAC Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2017-2022)
    Table 48. APAC Hip Osteoarthritis Pain Medicine Sales by Application (2017-2022) & (K Units)
    Table 49. APAC Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2017-2022)
    Table 50. Europe Hip Osteoarthritis Pain Medicine Sales by Country (2017-2022) & (K Units)
    Table 51. Europe Hip Osteoarthritis Pain Medicine Sales Market Share by Country (2017-2022)
    Table 52. Europe Hip Osteoarthritis Pain Medicine Revenue by Country (2017-2022) & ($ Millions)
    Table 53. Europe Hip Osteoarthritis Pain Medicine Revenue Market Share by Country (2017-2022)
    Table 54. Europe Hip Osteoarthritis Pain Medicine Sales by Type (2017-2022) & (K Units)
    Table 55. Europe Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2017-2022)
    Table 56. Europe Hip Osteoarthritis Pain Medicine Sales by Application (2017-2022) & (K Units)
    Table 57. Europe Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2017-2022)
    Table 58. Middle East & Africa Hip Osteoarthritis Pain Medicine Sales by Country (2017-2022) & (K Units)
    Table 59. Middle East & Africa Hip Osteoarthritis Pain Medicine Sales Market Share by Country (2017-2022)
    Table 60. Middle East & Africa Hip Osteoarthritis Pain Medicine Revenue by Country (2017-2022) & ($ Millions)
    Table 61. Middle East & Africa Hip Osteoarthritis Pain Medicine Revenue Market Share by Country (2017-2022)
    Table 62. Middle East & Africa Hip Osteoarthritis Pain Medicine Sales by Type (2017-2022) & (K Units)
    Table 63. Middle East & Africa Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2017-2022)
    Table 64. Middle East & Africa Hip Osteoarthritis Pain Medicine Sales by Application (2017-2022) & (K Units)
    Table 65. Middle East & Africa Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2017-2022)
    Table 66. Key Market Drivers & Growth Opportunities of Hip Osteoarthritis Pain Medicine
    Table 67. Key Market Challenges & Risks of Hip Osteoarthritis Pain Medicine
    Table 68. Key Industry Trends of Hip Osteoarthritis Pain Medicine
    Table 69. Hip Osteoarthritis Pain Medicine Raw Material
    Table 70. Key Suppliers of Raw Materials
    Table 71. Hip Osteoarthritis Pain Medicine Distributors List
    Table 72. Hip Osteoarthritis Pain Medicine Customer List
    Table 73. Global Hip Osteoarthritis Pain Medicine Sales Forecast by Region (2023-2028) & (K Units)
    Table 74. Global Hip Osteoarthritis Pain Medicine Sales Market Forecast by Region
    Table 75. Global Hip Osteoarthritis Pain Medicine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 76. Global Hip Osteoarthritis Pain Medicine Revenue Market Share Forecast by Region (2023-2028)
    Table 77. Americas Hip Osteoarthritis Pain Medicine Sales Forecast by Country (2023-2028) & (K Units)
    Table 78. Americas Hip Osteoarthritis Pain Medicine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 79. APAC Hip Osteoarthritis Pain Medicine Sales Forecast by Region (2023-2028) & (K Units)
    Table 80. APAC Hip Osteoarthritis Pain Medicine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 81. Europe Hip Osteoarthritis Pain Medicine Sales Forecast by Country (2023-2028) & (K Units)
    Table 82. Europe Hip Osteoarthritis Pain Medicine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 83. Middle East & Africa Hip Osteoarthritis Pain Medicine Sales Forecast by Country (2023-2028) & (K Units)
    Table 84. Middle East & Africa Hip Osteoarthritis Pain Medicine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 85. Global Hip Osteoarthritis Pain Medicine Sales Forecast by Type (2023-2028) & (K Units)
    Table 86. Global Hip Osteoarthritis Pain Medicine Sales Market Share Forecast by Type (2023-2028)
    Table 87. Global Hip Osteoarthritis Pain Medicine Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 88. Global Hip Osteoarthritis Pain Medicine Revenue Market Share Forecast by Type (2023-2028)
    Table 89. Global Hip Osteoarthritis Pain Medicine Sales Forecast by Application (2023-2028) & (K Units)
    Table 90. Global Hip Osteoarthritis Pain Medicine Sales Market Share Forecast by Application (2023-2028)
    Table 91. Global Hip Osteoarthritis Pain Medicine Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 92. Global Hip Osteoarthritis Pain Medicine Revenue Market Share Forecast by Application (2023-2028)
    Table 93. Pfizer Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 94. Pfizer Hip Osteoarthritis Pain Medicine Product Offered
    Table 95. Pfizer Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 96. Pfizer Main Business
    Table 97. Pfizer Latest Developments
    Table 98. Johnson and Johnson Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 99. Johnson and Johnson Hip Osteoarthritis Pain Medicine Product Offered
    Table 100. Johnson and Johnson Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 101. Johnson and Johnson Main Business
    Table 102. Johnson and Johnson Latest Developments
    Table 103. GlaxoSmithKline Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 104. GlaxoSmithKline Hip Osteoarthritis Pain Medicine Product Offered
    Table 105. GlaxoSmithKline Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 106. GlaxoSmithKline Main Business
    Table 107. GlaxoSmithKline Latest Developments
    Table 108. Bayer Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 109. Bayer Hip Osteoarthritis Pain Medicine Product Offered
    Table 110. Bayer Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 111. Bayer Main Business
    Table 112. Bayer Latest Developments
    Table 113. Eli Lilly Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 114. Eli Lilly Hip Osteoarthritis Pain Medicine Product Offered
    Table 115. Eli Lilly Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 116. Eli Lilly Main Business
    Table 117. Eli Lilly Latest Developments
    Table 118. Novartis Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 119. Novartis Hip Osteoarthritis Pain Medicine Product Offered
    Table 120. Novartis Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 121. Novartis Main Business
    Table 122. Novartis Latest Developments
    Table 123. Sanofi Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 124. Sanofi Hip Osteoarthritis Pain Medicine Product Offered
    Table 125. Sanofi Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 126. Sanofi Main Business
    Table 127. Sanofi Latest Developments
    Table 128. Horizon Pharma Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 129. Horizon Pharma Hip Osteoarthritis Pain Medicine Product Offered
    Table 130. Horizon Pharma Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 131. Horizon Pharma Main Business
    Table 132. Horizon Pharma Latest Developments
    Table 133. Abbott Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 134. Abbott Hip Osteoarthritis Pain Medicine Product Offered
    Table 135. Abbott Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 136. Abbott Main Business
    Table 137. Abbott Latest Developments
    Table 138. Mylan Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 139. Mylan Hip Osteoarthritis Pain Medicine Product Offered
    Table 140. Mylan Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 141. Mylan Main Business
    Table 142. Mylan Latest Developments
    Table 143. Daiichi Sankyo Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 144. Daiichi Sankyo Hip Osteoarthritis Pain Medicine Product Offered
    Table 145. Daiichi Sankyo Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 146. Daiichi Sankyo Main Business
    Table 147. Daiichi Sankyo Latest Developments
    Table 148. TEVA Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 149. TEVA Hip Osteoarthritis Pain Medicine Product Offered
    Table 150. TEVA Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 151. TEVA Main Business
    Table 152. TEVA Latest Developments
    Table 153. Almatica Pharma Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 154. Almatica Pharma Hip Osteoarthritis Pain Medicine Product Offered
    Table 155. Almatica Pharma Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 156. Almatica Pharma Main Business
    Table 157. Almatica Pharma Latest Developments
    Table 158. Astellas Pharma Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 159. Astellas Pharma Hip Osteoarthritis Pain Medicine Product Offered
    Table 160. Astellas Pharma Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 161. Astellas Pharma Main Business
    Table 162. Astellas Pharma Latest Developments
    Table 163. Tide Pharmaceutical Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 164. Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Product Offered
    Table 165. Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 166. Tide Pharmaceutical Main Business
    Table 167. Tide Pharmaceutical Latest Developments
    Table 168. Iroko Pharmaceuticals Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 169. Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Product Offered
    Table 170. Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 171. Iroko Pharmaceuticals Main Business
    Table 172. Iroko Pharmaceuticals Latest Developments
    Table 173. Hengrui Pharmaceutical Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 174. Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Product Offered
    Table 175. Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 176. Hengrui Pharmaceutical Main Business
    Table 177. Hengrui Pharmaceutical Latest Developments
    Table 178. Abiogen Pharma Basic Information, Hip Osteoarthritis Pain Medicine Manufacturing Base, Sales Area and Its Competitors
    Table 179. Abiogen Pharma Hip Osteoarthritis Pain Medicine Product Offered
    Table 180. Abiogen Pharma Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 181. Abiogen Pharma Main Business
    Table 182. Abiogen Pharma Latest Developments
List of Figures
    Figure 1. Picture of Hip Osteoarthritis Pain Medicine
    Figure 2. Hip Osteoarthritis Pain Medicine Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Hip Osteoarthritis Pain Medicine Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Hip Osteoarthritis Pain Medicine Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Hip Osteoarthritis Pain Medicine Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Oral
    Figure 10. Product Picture of Injection
    Figure 11. Product Picture of External
    Figure 12. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Type in 2021
    Figure 13. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Type (2017-2022)
    Figure 14. Hip Osteoarthritis Pain Medicine Consumed in Medical Care
    Figure 15. Global Hip Osteoarthritis Pain Medicine Market: Medical Care (2017-2022) & (K Units)
    Figure 16. Hip Osteoarthritis Pain Medicine Consumed in Personal Care
    Figure 17. Global Hip Osteoarthritis Pain Medicine Market: Personal Care (2017-2022) & (K Units)
    Figure 18. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2017-2022)
    Figure 19. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Application in 2021
    Figure 20. Hip Osteoarthritis Pain Medicine Revenue Market by Company in 2021 ($ Million)
    Figure 21. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Company in 2021
    Figure 22. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Geographic Region (2017-2022)
    Figure 23. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Geographic Region in 2021
    Figure 24. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Region (2017-2022)
    Figure 25. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Country/Region in 2021
    Figure 26. Americas Hip Osteoarthritis Pain Medicine Sales 2017-2022 (K Units)
    Figure 27. Americas Hip Osteoarthritis Pain Medicine Revenue 2017-2022 ($ Millions)
    Figure 28. APAC Hip Osteoarthritis Pain Medicine Sales 2017-2022 (K Units)
    Figure 29. APAC Hip Osteoarthritis Pain Medicine Revenue 2017-2022 ($ Millions)
    Figure 30. Europe Hip Osteoarthritis Pain Medicine Sales 2017-2022 (K Units)
    Figure 31. Europe Hip Osteoarthritis Pain Medicine Revenue 2017-2022 ($ Millions)
    Figure 32. Middle East & Africa Hip Osteoarthritis Pain Medicine Sales 2017-2022 (K Units)
    Figure 33. Middle East & Africa Hip Osteoarthritis Pain Medicine Revenue 2017-2022 ($ Millions)
    Figure 34. Americas Hip Osteoarthritis Pain Medicine Sales Market Share by Country in 2021
    Figure 35. Americas Hip Osteoarthritis Pain Medicine Revenue Market Share by Country in 2021
    Figure 36. United States Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 37. Canada Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Mexico Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Brazil Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 40. APAC Hip Osteoarthritis Pain Medicine Sales Market Share by Region in 2021
    Figure 41. APAC Hip Osteoarthritis Pain Medicine Revenue Market Share by Regions in 2021
    Figure 42. China Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Japan Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 44. South Korea Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 45. Southeast Asia Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 46. India Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Australia Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Europe Hip Osteoarthritis Pain Medicine Sales Market Share by Country in 2021
    Figure 49. Europe Hip Osteoarthritis Pain Medicine Revenue Market Share by Country in 2021
    Figure 50. Germany Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 51. France Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 52. UK Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Italy Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Russia Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Middle East & Africa Hip Osteoarthritis Pain Medicine Sales Market Share by Country in 2021
    Figure 56. Middle East & Africa Hip Osteoarthritis Pain Medicine Revenue Market Share by Country in 2021
    Figure 57. Egypt Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 58. South Africa Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Israel Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Turkey Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 61. GCC Country Hip Osteoarthritis Pain Medicine Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Manufacturing Cost Structure Analysis of Hip Osteoarthritis Pain Medicine in 2021
    Figure 63. Manufacturing Process Analysis of Hip Osteoarthritis Pain Medicine
    Figure 64. Industry Chain Structure of Hip Osteoarthritis Pain Medicine
    Figure 65. Channels of Distribution
    Figure 66. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Hip Osteoarthritis Pain Medicine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Hip Osteoarthritis Pain Medicine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Hip Osteoarthritis Pain Medicine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports